Anatolia Health Tech

Anatolia Health Tech is a pioneering investment platform dedicated to health technologies, emphasizing longevity and life sciences. With a mission to become a regional powerhouse, it seeks to transform Türkiye into a hub for innovative health technology development, supported by strong clinical infrastructure and scientific expertise. The firm manages a substantial $30 million fund, targeting high-growth investments over an eight-year period focusing on proven assets.

Anatolia Health Tech prioritizes a science-first, data-driven approach in its investment strategy, engaging in areas such as regenerative medicine, genomics, digital health, and cell and gene therapies. The platform is anchored by three key portfolio assets: Trustlife Therapeutics, Phenome Longevity, and TCT Health, each addressing critical dimensions of the health economy. With guidance from an internationally validated investment committee and a world-class scientific advisory board linked to top institutions, Anatolia Health Tech ensures rigorous governance and clear pathways for successful exits. Their ultimate aim is to advance health technology that contributes to a healthier future.